1. Department of Health and Aged Care. National immunisation program schedule. Published October 5, 2020. Accessed October 5, 2020. https://www.health.gov.au/health-topics/immunisation/immunisation-throughout-life/national-immunisation-program-schedule#national-immunisation-program-schedule-from-1-july-2020.
2. Therapeutic Goods Administration. AUSTRALIAN PRODUCT INFORMATION—NIMENRIX® (meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine). Published August 29, 2013; Revised January 12, 2023. Accessed November 1, 2023. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2013-PI-02123-1&d=20231101172310101
3. Therapeutic Goods Administration. AUSTRALIAN PRODUCT INFORMATION—M-M-R® II (measles, mumps and rubella virus vaccine live). Published February 14, 2006; Revised December 11, 2020. Accessed November 1, 2023. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00703-3
4. Therapeutic Goods Administration. AUSTRALIAN PRODUCT INFORMATION—Prevenar 13® (pneumococcal polysaccharide conjugate vaccine, 13-valent adsorbed). Published March 29, 2010; Revised August 13, 2020. Accessed November 1, 2023. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-07066-3